Clinical Trial Update: HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating HER2-directed CAR T cells in pediatric patients with ependymoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma

Drugs mentioned

• HER2-specific CAR-T cells

Snippet

Sponsor: Children's Oncology Group | Conditions: Ependymoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING